Omada Health Resource Center
In a survey of over 2,000 doctors, a majority believed GLP-1s need to be paired with changes in diet and exercise to be effective in driving healthy weight loss.
Read Article
Omada Health GLP-1 Care Track
Learn MoreWhat do doctors think of GLP-1s? New survey reveals prescription trends, patient safety concerns, and how telehealth prescribers affect care amidst rising demand for weight loss medications.
Read Resource
Share your story with us a HLTH 2025 in Las Vegas!
Read Article
Join Omada Health at AHIP 2025 to connect with industry leaders, explore innovative solutions, and shape healthcare's future.
Read Article
Pioneering the Future at the Lockton People Solutions Conference 2025
Read Article
Leading the charge as a Diamond sponsor for the SALGBA 2025 National Conference.
Read Article
Omada Health returns to Health Evolution Summit 2025!
Read Article
Omada Health is proud to host an exclusive HR Peer150 experience!
Read Article
Engage with Omada Health at Thrive Summit 2025 in Orlando, FL!
Read Article
We are proud to support HRPA's 57th Annual CHRO Summit again this year. We value fostering connections and look forward to the engaging agenda on the latest questions HR leaders are facing.
Read Article
Meaningful engagement improves patient outcomes in virtual care programs, including GLP-1 programs. Find out which types of engagement are effective.
Read Article
Real-world data analysis shows Omada members, on average, experienced virtually no weight gain 16 weeks after discontinuing a GLP-1 compared to an average of 6-7% weight gain estimated from trial data
Read Article
Is keeping weight off after GLP-1s a concern for your members? Omada’s 16-week analysis reveals how tailored tools and support can help lead to successful weight maintenance.
Read Resource
Discover early outcomes and insights on health behavior and weight loss with Omada's Enhanced GLP-1 Care Track, specifically designed for individuals on GLP-1s seeking supportive programs.
Read Resource
The collaboration between Stanford Health Care and Omada demonstrates the value of engaging with providers and health systems to realize the value of virtual care.
Read Resource
Survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals; respondents want to lose an average of 22% more weight.
Read Article
Omada Health GLP-1 Care Track
Learn MoreOmada Insights Lab surveyed and interviewed Omada members with a history of GLP-1 use to learn more about their unique needs and experiences.
Read Resource
Cardiovascular disease (CVD) remains the leading cause of death among women, yet it is often misdiagnosed and/or undertreated. Join the discussion on the need for more focus on women's heart health.
Watch Video
New consumer data indicates that sustaining weight loss and overall well-being requires intervention beyond the GLP-1
Read Resource
Return on Health Framework for Realizing the Value of Virtual Care
Read Resource
Loading More...
